EditorialFull Access
Published Online:1 Sep 2009https://doi.org/10.1176/appi.ajp.2009.09050619
- Cited by
- Adverse Drug Reaction Bulletin, Vol. 299, No. 1
- Benedetto Vitiello,
M.D. , - Glen R. Elliott,
M.D., Ph.D. , - James M. Swanson,
Ph.D. , - L. Eugene Arnold,
M.D. , - Lily Hechtman,
M.D. , - Howard Abikoff,
Ph.D. , - Brooke S.G. Molina,
Ph.D. , - Karen Wells,
Ph.D. , - Timothy Wigal,
Ph.D. , - Peter S. Jensen,
M.D. , - Laurence L. Greenhill,
M.D. , - Jonathan R. Kaltman,
M.D. , - Joanne B. Severe,
M.S. , - Carol Odbert,
B.S. , - Kwan Hur,
Ph.D. , and - Robert Gibbons,
Ph.D.
1 February 2012 | American Journal of Psychiatry, Vol. 169, No. 2- Benedetto Vitiello,
- 8 July 2010 | Expert Opinion on Drug Safety, Vol. 9, No. 6
- CONTINUUM: Lifelong Learning in Neurology, Vol. 15
Metrics
History
Published online 1 September 2009
Published in print 1 September 2009